Aesthetics examines the recent UKHSA public warning about rising botulism cases linked to counterfeit botulinum toxin
The UK Health Security Agency (UKHSA) has issued a warning to the public following botulism cases connected to counterfeit botulinum toxin.1 Between June 4 and July 14, 2025, approximately 38 patients became critically ill with botulism, primarily in the East of England and East Midlands.1,2
The UKHSA reported that initial cases were identified in the North East of England, with subsequent cases emerging in the East of England and East Midlands.1,2 The initial cluster of cases was identified when County Durham and Darlington NHS Foundation Trust raised concerns, after several patients presented with neurological symptoms following cosmetic injections.1,2
Reported symptoms include ptosis, diplopia, dysphagia, slurred speech, lethargy and, in severe cases, respiratory distress.1,2 It is suspected that an “unlicensed Botox-like product,” was illegally administered by unqualified beauticians…
